AGÕæÈ˹ٷ½

STOCK TITAN

DarioHealth to Report Second Quarter 2025 Results on Tuesday, August 12, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

DarioHealth (Nasdaq: DRIO), a leader in the global digital health market, will release its Q2 2025 financial results on Tuesday, August 12th, 2025. The company will host a conference call and webcast at 8:30 a.m. Eastern Time, before market opens.

The earnings call will be hosted by CEO Erez Raphael, President and CCO Steven Nelson, and CFO Chen Franco-Yehuda. Participants can join via dial-in numbers or through the Call me� link, which will be active 15 minutes before the call. A replay will be available until August 26th, 2025.

DarioHealth (Nasdaq: DRIO), leader nel mercato globale della salute digitale, pubblicherà i suoi risultati finanziari del secondo trimestre 2025 martedì 12 agosto 2025. La società terrà una conference call e una webcast alle 8:30 a.m. ora orientale, prima dell'apertura del mercato.

La chiamata sugli utili sarà condotta dal CEO Erez Raphael, dal Presidente e CCO Steven Nelson e dal CFO Chen Franco-Yehuda. I partecipanti potranno collegarsi tramite numeri di telefono o tramite il link Call me�, attivo 15 minuti prima della chiamata. La registrazione sarà disponibile fino al 26 agosto 2025.

DarioHealth (Nasdaq: DRIO), líder en el mercado global de salud digital, publicará sus resultados financieros del segundo trimestre de 2025 el martes 12 de agosto de 2025. La compañía realizará una llamada conferencia y una transmisión web a las 8:30 a.m. hora del Este, antes de la apertura del mercado.

La llamada de resultados será dirigida por el CEO Erez Raphael, el Presidente y CCO Steven Nelson, y el CFO Chen Franco-Yehuda. Los participantes podrán unirse mediante números de marcación o a través del enlace Call me�, que estará activo 15 minutos antes de la llamada. Una repetición estará disponible hasta el 26 de agosto de 2025.

DarioHealth (나스ë‹�: DRIO)ëŠ� 글로벌 디지í„� 헬스 시장ì� ì„ ë‘주ìžë¡œì„œ 2025ë…� 2분기 실ì ì� 2025ë…� 8ì›� 12ì� 화요ì¼ì— 발표í•� 예정입니ë‹�. 회사ëŠ� 시장 개장 ì „ì— ë™ë¶€ 표준ì‹� 오전 8ì‹� 30ë¶�ì—� 컨í¼ëŸ°ìФ 콜과 웹ìºìŠ¤íŠ¸ë¥� 진행합니ë‹�.

ì‹¤ì  ë°œí‘œ ì½œì€ CEO ì—ë ˆì¦� ë¼íŒŒì—�, 사장 ê²� CCO 스티ë¸� 넬슨, CFO ì²� 프랑ì½�-예후다가 진행합니ë‹�. 참가ìžëŠ” ì „í™” ì ‘ì† ë²ˆí˜¸ë‚� ì½� ë¯�(Call meâ„�) ë§í¬ë¥� 통해 참여í•� ìˆ� 있으ë©�, ì� ë§í¬ëŠ� ì½� 시작 15ë¶� ì „ì— í™œì„±í™”ë©ë‹ˆë‹¤. 재청취는 2025ë…� 8ì›� 26ì¼ê¹Œì§€ 가능합니다.

DarioHealth (Nasdaq : DRIO), leader sur le marché mondial de la santé numérique, publiera ses résultats financiers du deuxième trimestre 2025 le mardi 12 août 2025. La société organisera une conférence téléphonique et une webdiffusion à 8h30, heure de l'Est, avant l'ouverture des marchés.

La conférence sur les résultats sera animée par le PDG Erez Raphael, le président et CCO Steven Nelson, ainsi que le CFO Chen Franco-Yehuda. Les participants pourront se joindre via des numéros d'appel ou via le lien Call me�, qui sera actif 15 minutes avant la conférence. Une rediffusion sera disponible jusqu'au 26 août 2025.

DarioHealth (Nasdaq: DRIO), ein führendes Unternehmen im globalen digitalen Gesundheitsmarkt, wird am Dienstag, den 12. August 2025, seine Finanzergebnisse für das zweite Quartal 2025 veröffentlichen. Das Unternehmen wird eine Telefonkonferenz und ein Webcast um 8:30 Uhr Eastern Time vor Markteröffnung abhalten.

Die Ergebnispräsentation wird vom CEO Erez Raphael, Präsident und CCO Steven Nelson sowie CFO Chen Franco-Yehuda geleitet. Teilnehmer können sich über Einwahlnummern oder über den Call me�-Link einwählen, der 15 Minuten vor Beginn der Konferenz aktiviert wird. Eine Aufzeichnung wird bis zum 26. August 2025 verfügbar sein.

Positive
  • None.
Negative
  • None.

Company to host conference call and webcast at 8:30 a.m. Eastern Time

NEW YORK, Aug. 5, 2025 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today that it will release its financial results for the 2nd quarter ended June 30th, 2025 and will host a conference call and webcast at 8:30 a.m. Eastern Time, on Tuesday, August 12th, 2025, before the market opens.

DarioHealth Corp. logo

Erez Raphael, Chief Executive Officer, Steven Nelson, President and Chief Commercial Officer, and Chen Franco-Yehuda, Chief Financial Officer, will host the call.

Conference Call Details

Date: Tuesday, August 12th, 2025, 8:30 a.m. Eastern Time 
Dial-in Number: 1-800-717-1738 (domestic) or 1-646-307-1865 (international) 
Call me�: 

Participants can use the dial-in numbers above and be answered by an operator OR click the Call me� link for instant telephone access to the event. This link will be made active 15 minutes prior to the scheduled start time.

Webcast link: 

Participants are asked to dial in approximately 10 minutes prior to the start of the event. A replay of the call will be available approximately three hours after completion of the conference call through Tuesday, August 26th, 2025. To listen to the replay, dial 1-844-512-2921 (domestic) or 1-412-317-6671 (international) and use replay passcode 1195394.

About DarioHealth Corp.

DarioHealth Corp. (Nasdaq: DRIO) is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric, multi-chronic condition digital therapeutics platform. Dario's platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. 

Dario's user-centric platform offers people continuous and customized care for their health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results and making the right thing to do the easy thing to do.

Dario provides its highly user-rated solutions globally to health plans and other payers, self-insured employers, providers of care and consumers. To learn more about Dario and its digital health solutions, or for more information, visit .

Cautionary Note Regarding Forward-Looking Statements

This news release and the statements of representatives and partners of DarioHealth Corp. related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. For example, the Company is using forward-looking statements in this press release when it discusses the expected date of its earnings release. Without limiting the generality of the foregoing, words such as "plan," "project," "potential," "seek," "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate" or "continue" are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect the Company's results include, but are not limited to, regulatory approvals, product demand, market acceptance, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks, and the risks associated with the adequacy of existing cash resources. Additional factors that could cause or contribute to differences between the Company's actual results and forward-looking statements include, but are not limited to, those risks discussed in the Company's filings with the U.S. Securities and Exchange Commission. Readers are cautioned that actual results (including, without limitation, the timing for and results of the Company's commercial and regulatory plans for Dario� as described herein) may differ significantly from those set forth in the forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

DarioHealth Corporate Contact
Mary Mooney 
VP Marketing 
[email protected]
+1-312-593-4280

DarioHealth Investor Relations Contact
Michael Lipari
SVP Corporate Development 
[email protected]
+1-203-785-6310

Logo - https://mma.prnewswire.com/media/1920436/DarioHealth_Logo.jpg

Cision View original content:

SOURCE DarioHealth Corp.

FAQ

When will DarioHealth (DRIO) report Q2 2025 earnings?

DarioHealth will report Q2 2025 earnings on Tuesday, August 12th, 2025, before the market opens.

How can investors access DarioHealth's Q2 2025 earnings call?

Investors can join via dial-in (1-800-717-1738 domestic, 1-646-307-1865 international), the Call me� link, or webcast at 8:30 a.m. Eastern Time.

Who will host DarioHealth's Q2 2025 earnings call?

The call will be hosted by CEO Erez Raphael, President and CCO Steven Nelson, and CFO Chen Franco-Yehuda.

How long will DarioHealth's Q2 2025 earnings call replay be available?

The earnings call replay will be available until Tuesday, August 26th, 2025, accessible via domestic (1-844-512-2921) or international (1-412-317-6671) numbers.
Dariohealth Corp

NASDAQ:DRIO

DRIO Rankings

DRIO Latest News

DRIO Latest SEC Filings

DRIO Stock Data

24.57M
35.68M
19.69%
16.66%
6.66%
Health Information Services
Surgical & Medical Instruments & Apparatus
United States
NEW YORK